Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Clinical trial NCT00083954 · COMPLETED

Trial details

NCT number: NCT00083954
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2004-06-01
Enrollment: 530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.